CVE-2019-18256BIOTRONIK CardioMessenger II, The affected products use individual per-device credentials that are stored in a recoverable format.
Updated under an hour ago ()
Does this affect you?
It affects biotronik cardiomessenger_ii-s_gsm_firmware and 1 other product. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.36%, higher than 28% of scored CVEs.
Do this next
Free account, 1 product
BIOTRONIK CardioMessenger II, The affected products use individual per-device credentials that are stored in a recoverable format. An attacker with physical access to the CardioMessenger can use these credentials for network authentication and decryption of local data in transit.
- CVSS
- 4.6 MEDIUM (v3.1, NVD)CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
- Weakness (CWE)
- CWE-257
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.36% (percentile 28)
- Assigned by
- icscert
- NVD analysis
- Modified
- Record last updated
- Aug 5, 2024
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
biotronik cardiomessenger_ii-s_gsm_firmware biotronik:cardiomessenger_ii-s_gsm_firmware | 2.20 | NVD |
biotronik cardiomessenger_ii-s_t-line_firmware biotronik:cardiomessenger_ii-s_t-line_firmware | 2.20 | NVD |
References
- https://www.us-cert.gov/ics/advisories/icsma-20-170-05x-refsource-misc, third-party-advisory, us-government-resource
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.